SUNESIS PHARMACEUTICALS INC - COM PAR (SNSS) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2016 to Q1 2021

Type / Class
Equity / COM PAR
Symbol
SNSS
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of SUNESIS PHARMACEUTICALS INC - COM PAR (SNSS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2021 Q1 0 $0 -$2,555,000 0
2020 Q4 1,400,590 $2,555,000 -$36,000 $1.99 5
2020 Q3 1,438,656 $1,652,000 -$21,215,364 $1.25 5
2020 Q2 37,779,369 $9,948,000 -$11,764,858 $0.26 33
2020 Q1 67,441,197 $27,977,000 +$3,982,206 $0.41 39
2019 Q4 58,036,460 $19,601,000 -$7,089,874 $0.34 38
2019 Q3 59,077,661 $42,529,000 +$16,188,006 $0.72 43
2019 Q2 36,568,980 $26,602,000 +$1,362,718 $0.73 39
2019 Q1 30,099,814 $36,561,000 +$18,534,937 $1.22 40
2018 Q4 15,418,963 $6,419,000 -$6,571,907 $0.42 33
2018 Q3 16,519,945 $33,039,000 +$1,383,504 $2.00 44
2018 Q2 15,813,186 $33,521,000 -$6,186,331 $2.12 42
2018 Q1 17,949,366 $48,820,000 -$844,156 $2.72 44
2017 Q4 18,215,532 $67,216,000 +$21,271,488 $3.69 35
2017 Q3 13,081,398 $25,379,000 -$1,313,400 $1.94 31
2017 Q2 13,527,166 $36,525,000 +$3,399,536 $2.70 30
2017 Q1 11,869,480 $48,664,000 +$468,315 $4.10 34
2016 Q4 11,858,332 $42,923,601 +$18,706,884 $3.62 39
2016 Q3 6,649,700 $29,060,000 +$29,060,000 $4.37 30